oxycodone has been researched along with Low Back Pain in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (20.41) | 29.6817 |
2010's | 35 (71.43) | 24.3611 |
2020's | 4 (8.16) | 2.80 |
Authors | Studies |
---|---|
Del Balzo, G; Donadello, K; Gottin, L; Marinangeli, F; Martini, A; Nizzero, M; Polati, E; Rama, J; Schweiger, V; Secchettin, E; Varrassi, G; Vittori, A | 1 |
Billot, L; Day, RO; Jones, CMP; Koes, BW; Latimer, J; Lin, CC; Maher, CG; McLachlan, AJ; Shan, S | 1 |
Bass, A; Pixton, GC; Rauck, RL; Wilson, JG; Wolfram, G | 1 |
Becker, WC; Edens, EL; Frank, JW | 1 |
Kopecky, EA; Lagasse, S; O'Connor, M; Vaughn, B | 1 |
Arendt-Nielsen, L; Bütikofer, L; Curatolo, M; Jüni, P; Schliessbach, J; Siegenthaler, A; Vuilleumier, P | 1 |
Jääskeläinen, SK | 1 |
Barsdorf, AI; Bass, A; Masters, ET; Pixton, G; Weil, AJ; Wilson, JG; Wolfram, G | 1 |
Arendt-Nielsen, L; Bütikofer, L; Curatolo, M; Jüni, P; Schliessbach, J; Siegenthaler, A; Stamer, U; Vuilleumier, P | 1 |
Blackney, KA; Edwards, DA; Kamdar, NV; Liu, CA | 1 |
Falke, D; Gálvez, R; Hans, G; Schäfer, M; Steigerwald, I | 1 |
Bednarova, R; Miceli, L; Rizzardo, A; Rocca, GD; Sandri, M | 1 |
Hammond, G; Kavanagh, S; Kwong, WJ; Okamoto, A; Upmalis, D; Yang, M | 1 |
Etropolski, M; Flügel, M; Häufel, T; Kuperwasser, B; Lange, B; Laschewski, F; Rauschkolb, C | 1 |
Benson, C; Biondi, DM; Dworkin, RH; Katz, NP; Kim, M; Trudeau, JJ; Turk, DC | 1 |
Plotzker, DA | 1 |
Mueller-Schwefe, GH; Ueberall, MA | 1 |
Bass, A; Bramson, C; Hale, ME; Malhotra, BK; Meisner, P; Pixton, G; Rauck, RL; Setnik, B; Sommerville, KW; Wilson, JG; Wolfram, G | 1 |
Alarcão, J; Costa, J; Fareleira, F; Santos, J; Vaz-Carneiro, A | 1 |
Baron, R; Blanco, FJ; Falke, D; Kennes, L; Likar, R; Martin-Mola, E; Müller, M; Steigerwald, I | 1 |
Baum, K; Eberitsch, J; Niemier, K; Schindler, M; Seidel, W; Volk, T; Wolf, B | 1 |
Brown, RH; Fleming, AB; Katz, N; Kopecky, EA; O'Connor, M | 1 |
Arendt-Nielsen, L; Curatolo, M; Juni, P; Schliessbach, J; Siegenthaler, A; Vuilleumier, PH; Zeilhofer, HU | 1 |
Arsenault, P; Buynak, R; Etropolski, M; Heisig, F; Rappaport, SA; Rauschkolb, C; Rod, K | 1 |
Bijur, PE; Davitt, M; Dym, AA; Esses, D; Friedman, BW; Gallagher, EJ; Holden, L; Solorzano, C | 1 |
Baron, R; Binder, A; Falke, D; Jansen, JP; Kennes, L; Müller, M; Pombo-Suarez, M; Steigerwald, I | 1 |
Carpenter, CR | 1 |
Davis, MP | 1 |
Frazer, K; Stevermer, JJ | 1 |
Billot, L; Day, RO; Koes, BW; Latimer, J; Lin, CW; Maher, CG; McLachlan, AJ | 1 |
Kennedy, DJ; Kumbhare, D; Schneider, BJ | 1 |
Gottlieb, M; Njie, A | 1 |
Fleischer, W; Grothe, B; Hermanns, K; Hopp, M; Leyendecker, P; Meissner, W; Reimer, K; Ruckes, C; Szombati, I; Vondrackova, D; Weber, S | 1 |
Hale, M; Lange, C; Okamoto, A; Rauschkolb, C; Upmalis, D | 1 |
Bertini, L; Carucci, A; Gatti, A; Mammucari, M; Occhioni, R; Sabato, AF | 1 |
Gould, EM; Peniston, JH; Xiang, Q | 1 |
Ashworth, J; Etropolski, M; Häufel, T; Kuperwasser, B; Lange, B; Okamoto, A; Steup, A | 1 |
Friedmann, N; Klutzaritz, V; Webster, L | 1 |
Hale, M; Landau, C; Munera, C; Ripa, S; Steiner, D | 1 |
Hammond, GC; Kavanagh, S; Kwong, WJ; Nelson, W; Upmalis, D; Yang, M | 1 |
Tenore, PL | 1 |
Bansal, M; Happich, M; Klein, R; Wielage, R; Wilson, K | 1 |
Fleischman, J; Galler, D | 1 |
Domingos, J; Galer, BS; Gammaitoni, AR; Lacouture, P; Schlagheck, T | 1 |
Dvergsten, C; Gimbel, J; Hale, ME | 1 |
Naliboff, BD; Pham, Q; Wu, SM | 1 |
Burns, LH; Butera, PG; Friedmann, N; Moran, LV; Webster, LR; Wu, N | 1 |
Burgess, FW | 1 |
Dornseif, BE; Doyle, RT; Morris, E; Palangio, M; Valente, TJ | 1 |
5 review(s) available for oxycodone and Low Back Pain
Article | Year |
---|---|
Safety and tolerability of tapentadol extended release in moderate to severe chronic osteoarthritis or low back pain management: pooled analysis of randomized controlled trials.
Topics: Adult; Aged; Analgesics; Chronic Pain; Delayed-Action Preparations; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Low Back Pain; Male; Middle Aged; Osteoarthritis, Hip; Osteoarthritis, Knee; Oxycodone; Pain Management; Pain Measurement; Phenols; Randomized Controlled Trials as Topic; Receptors, Opioid, mu; Tapentadol; Treatment Outcome | 2014 |
Tapentadol for chronic musculoskeletal pain in adults.
Topics: Adult; Analgesics, Opioid; Chronic Pain; Clinical Trials, Phase III as Topic; Humans; Low Back Pain; Musculoskeletal Pain; Osteoarthritis, Knee; Oxycodone; Phenols; Randomized Controlled Trials as Topic; Tapentadol | 2015 |
Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain.
Topics: Analgesics, Opioid; Animals; Chronic Pain; Delayed-Action Preparations; Drug Combinations; Humans; Low Back Pain; Naltrexone; Opioid-Related Disorders; Oxycodone; Practice Guidelines as Topic | 2016 |
Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain.
Topics: Aged; Analgesics, Opioid; Analysis of Variance; Chronic Disease; Clinical Trials, Phase III as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Least-Squares Analysis; Low Back Pain; Male; Middle Aged; Osteoarthritis, Knee; Oxycodone; Pain Measurement; Phenols; Quality of Life; Randomized Controlled Trials as Topic; Safety; Severity of Illness Index; Tapentadol; Treatment Outcome | 2010 |
Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective.
Topics: Age Factors; Aged; Amitriptyline; Analgesics; Cardiovascular Diseases; Celecoxib; Chronic Disease; Clinical Trials as Topic; Cost-Benefit Analysis; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Gastrointestinal Diseases; Humans; Hydromorphone; Low Back Pain; Markov Chains; Middle Aged; Models, Economic; Naproxen; Ontario; Osteoarthritis; Outcome Assessment, Health Care; Oxycodone; Pregabalin; Pyrazoles; Quality-Adjusted Life Years; Quebec; Sulfonamides; Thiophenes | 2013 |
29 trial(s) available for oxycodone and Low Back Pain
Article | Year |
---|---|
Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial.
Topics: Acute Pain; Adolescent; Adult; Analgesia; Analgesics, Opioid; Australia; Female; Humans; Low Back Pain; Male; Neck Pain; Oxycodone | 2023 |
Tolerability, Safety, and Effectiveness of Oxycodone DETERx in Elderly Patients ≥65 Years of Age with Chronic Low Back Pain: A Randomized Controlled Trial.
Topics: Aged; Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Low Back Pain; Male; Middle Aged; Oxycodone; Pain Measurement; Treatment Outcome | 2017 |
Quantitative sensory tests fairly reflect immediate effects of oxycodone in chronic low-back pain.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Female; Humans; Low Back Pain; Male; Middle Aged; Oxycodone; Pain Measurement; Pain Threshold; Treatment Outcome | 2017 |
Patient-reported health-related quality of life, work productivity, and activity impairment during treatment with ALO-02 (extended-release oxycodone and sequestered naltrexone) for moderate-to-severe chronic low back pain.
Topics: Adult; Analgesics, Opioid; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Efficiency; Female; Humans; Low Back Pain; Male; Middle Aged; Naltrexone; Oxycodone; Pain Measurement; Patient Reported Outcome Measures; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Visual Analog Scale | 2017 |
Predicting drug efficacy in chronic low back pain by quantitative sensory tests.
Topics: Adult; Aged; Analgesics; Clobazam; Cross-Over Studies; Double-Blind Method; Electric Stimulation; Female; Humans; Imipramine; Low Back Pain; Male; Middle Aged; Oxycodone; Pain Measurement; Pain Threshold; Pressure | 2018 |
Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Constipation; Delayed-Action Preparations; Female; Fentanyl; Humans; Hydromorphone; Low Back Pain; Male; Middle Aged; Morphine; Neuralgia; Oxycodone; Pain Measurement; Phenols; Severity of Illness Index; Tapentadol | 2013 |
Bowel function after tapentadol and oxycodone immediate release (IR) treatment in patients with low back or osteoarthritis pain.
Topics: Adolescent; Adult; Analgesics, Opioid; Constipation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Gastroenteritis; Humans; Laxatives; Low Back Pain; Male; Osteoarthritis; Oxycodone; Pain; Phenols; Surveys and Questionnaires; Tapentadol; Time Factors; Young Adult | 2013 |
Validation of the Short-form McGill Pain Questionnaire-2 (SF-MPQ-2) in acute low back pain.
Topics: Acute Pain; Analgesics, Opioid; Double-Blind Method; Factor Analysis, Statistical; Female; Humans; Leg; Low Back Pain; Male; Middle Aged; Neuralgia; Oxycodone; Pain Measurement; Phenols; Psychometrics; Reproducibility of Results; Surveys and Questionnaires; Tapentadol | 2015 |
Safety and efficacy of oxycodone/naloxone vs. oxycodone vs. morphine for the treatment of chronic low back pain: results of a 12 week prospective, randomized, open-label blinded endpoint streamlined study with prolonged-release preparations.
Topics: Adult; Aged; Analgesics, Opioid; Constipation; Delayed-Action Preparations; Drug Combinations; Female; Germany; Humans; Low Back Pain; Male; Middle Aged; Morphine; Naloxone; Oxycodone; Prospective Studies; Young Adult | 2015 |
A randomized double-blind, placebo-controlled efficacy and safety study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) for moderate-to-severe chronic low back pain treatment.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Analysis of Variance; Chronic Pain; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Humans; Low Back Pain; Middle Aged; Naltrexone; Narcotic Antagonists; Oxycodone; Pain Measurement; Treatment Outcome; Young Adult | 2015 |
Effectiveness of Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-Label, Phase 3b/4 Study.
Topics: Adult; Aged; Analgesics, Opioid; Delayed-Action Preparations; Endpoint Determination; Female; Humans; Low Back Pain; Male; Middle Aged; Naloxone; Narcotic Antagonists; Neuralgia; Oxycodone; Pain Measurement; Phenols; Tapentadol | 2016 |
[Efficacy of epidural steroid injections for chronic lumbar pain syndromes without neurological deficits. A randomized, double blind study as part of a multimodal treatment concept].
Topics: Adult; Aged; Analgesia, Epidural; Bupivacaine; Combined Modality Therapy; Discitis; Double-Blind Method; Drug Therapy, Combination; Etoricoxib; Female; Humans; Injections, Epidural; Intention to Treat Analysis; Low Back Pain; Male; Middle Aged; Oxycodone; Pain Measurement; Physical Therapy Modalities; Placebo Effect; Prospective Studies; Pyridines; Randomized Controlled Trials as Topic; Sulfones; Tilidine; Triamcinolone | 2015 |
A phase 3, multicenter, randomized, double-blind, placebo-controlled, safety, tolerability, and efficacy study of Xtampza ER in patients with moderate-to-severe chronic low back pain.
Topics: Adult; Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Low Back Pain; Male; Middle Aged; Oxycodone; Pain Measurement; Severity of Illness Index; Treatment Outcome | 2015 |
Linking altered central pain processing and genetic polymorphism to drug efficacy in chronic low back pain.
Topics: Adolescent; Adult; Aged; Analgesics; Benzodiazepines; Chronic Pain; Clinical Protocols; Clobazam; Cross-Over Studies; Double-Blind Method; Female; Humans; Imipramine; Low Back Pain; Male; Middle Aged; Oxycodone; Pain Measurement; Polymorphism, Genetic; Young Adult | 2015 |
Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial.
Topics: Aged; Chronic Disease; Chronic Pain; Cross-Over Studies; Delayed-Action Preparations; Female; Humans; Low Back Pain; Male; Middle Aged; Osteoarthritis, Knee; Oxycodone; Phenols; Quality of Life; Tapentadol | 2015 |
Naproxen With Cyclobenzaprine, Oxycodone/Acetaminophen, or Placebo for Treating Acute Low Back Pain: A Randomized Clinical Trial.
Topics: Acetaminophen; Acute Disease; Adult; Aged; Amitriptyline; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Drug Combinations; Emergency Service, Hospital; Female; Humans; Low Back Pain; Male; Middle Aged; Muscle Relaxants, Central; Naproxen; Oxycodone; Pain Measurement; Treatment Outcome | 2015 |
Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-label, Phase 3b/4 Trial.
Topics: Adult; Aged; Analgesics, Opioid; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Endpoint Determination; Female; Health Status; Humans; Low Back Pain; Male; Middle Aged; Naloxone; Narcotic Antagonists; Neuralgia; Oxycodone; Pain Measurement; Phenols; Quality of Life; Tapentadol | 2016 |
OPAL: a randomised, placebo-controlled trial of opioid analgesia for the reduction of pain severity in people with acute spinal pain. Trial protocol.
Topics: Acute Pain; Adolescent; Adult; Aged; Analgesics, Opioid; Australia; Cost-Benefit Analysis; Female; Humans; Low Back Pain; Male; Middle Aged; Naloxone; Neck Pain; Oxycodone; Pain Measurement; Research Design; Young Adult | 2016 |
Comparison of naproxen with cyclobenzaprine, oxycodone-acetaminophen, and placebo for the treatment of acute low back pain.
Topics: Acetaminophen; Acute Disease; Administration, Oral; Adult; Amitriptyline; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Emergency Service, Hospital; Female; Follow-Up Studies; Hospitals, Teaching; Humans; Low Back Pain; Male; Middle Aged; Naproxen; Oxycodone; Pain Measurement; Patient Satisfaction; Severity of Illness Index; Treatment Outcome; Young Adult | 2016 |
Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.
Topics: Analgesics, Opioid; Chronic Disease; Constipation; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Low Back Pain; Male; Naloxone; Narcotic Antagonists; Oxycodone; Pain Measurement; Severity of Illness Index; Time Factors; Treatment Outcome | 2008 |
Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Double-Blind Method; Drug Administration Schedule; Drug Compounding; Female; Humans; Low Back Pain; Male; Middle Aged; Models, Biological; Osteoarthritis, Hip; Osteoarthritis, Knee; Oxycodone; Pain; Phenols; Tapentadol; Time Factors; Treatment Outcome | 2009 |
Adequacy assessment of oxycodone/paracetamol (acetaminophen) in multimodal chronic pain : a prospective observational study.
Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Amines; Analgesics, Non-Narcotic; Analgesics, Opioid; Chronic Disease; Cyclohexanecarboxylic Acids; Drug Combinations; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Low Back Pain; Male; Middle Aged; Osteoarthritis; Oxycodone; Pain; Pain Measurement; Peripheral Nervous System Diseases; Prospective Studies | 2009 |
Long-term safety of Remoxy® (extended-release oxycodone) in patients with moderate to severe chronic osteoarthritis or low back pain.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Arthralgia; Chronic Disease; Delayed-Action Preparations; Female; Humans; Low Back Pain; Male; Middle Aged; Osteoarthritis; Oxycodone; Pain Measurement; Treatment Outcome; Young Adult | 2011 |
Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study.
Topics: Administration, Cutaneous; Analgesics, Opioid; Buprenorphine; Chronic Pain; Double-Blind Method; Female; Humans; Low Back Pain; Male; Middle Aged; Oxycodone; Transdermal Patch; Treatment Outcome | 2011 |
Pain relief and tolerability balance of immediate release tapentadol or oxycodone treatment for patients with moderate to severe osteoarthritis or low back pain.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Low Back Pain; Male; Middle Aged; Osteoarthritis; Oxycodone; Phenols; Tapentadol; Young Adult | 2012 |
Effectiveness and safety of new oxycodone/acetaminophen formulations with reduced acetaminophen for the treatment of low back pain.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Female; Humans; Low Back Pain; Male; Middle Aged; Oxycodone; Prospective Studies; Treatment Outcome | 2003 |
Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Chronic Disease; Constipation; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Low Back Pain; Male; Middle Aged; Oxycodone; Oxymorphone; Pain Measurement; Placebo Effect; Placebos; Sleep Stages; Treatment Outcome | 2005 |
Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain.
Topics: Adolescent; Adult; Aged; Analgesics; Analysis of Variance; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Low Back Pain; Male; Middle Aged; Naltrexone; Oxycodone; Pain Measurement; Substance Withdrawal Syndrome; Treatment Outcome | 2006 |
Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of moderate or severe acute low back pain.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Drug Combinations; Female; Humans; Hydrocodone; Ibuprofen; Low Back Pain; Male; Middle Aged; Oxycodone; Pain Measurement | 2002 |
15 other study(ies) available for oxycodone and Low Back Pain
Article | Year |
---|---|
Oxycodone-Naloxone Combination Hinders Opioid Consumption in Osteoarthritic Chronic Low Back Pain: A Retrospective Study with Two Years of Follow-Up.
Topics: Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Drug Combinations; Drug Tolerance; Follow-Up Studies; Humans; Low Back Pain; Naloxone; Narcotic Antagonists; Oxycodone; Retrospective Studies | 2022 |
Safety and tolerability of ALO-02 (oxycodone hydrochloride and sequestered naltrexone hydrochloride) extended-release capsules in older patients: a pooled analysis of two clinical trials.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Low Back Pain; Male; Middle Aged; Naltrexone; Oxycodone; Randomized Controlled Trials as Topic; Young Adult | 2020 |
Switching From High-Dose, Long-Term Opioids to Buprenorphine: A Case Series.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Humans; Low Back Pain; Male; Middle Aged; Oxycodone | 2020 |
Quantitative sensory tests (QST) are promising tests for clinical relevance of anti-nociceptive effects of new analgesic treatments.
Topics: Analgesics; Humans; Low Back Pain; Oxycodone; Pain Threshold | 2017 |
Methylnaltrexone-Associated Bowel Perforation in Postoperative Opioid-Induced Constipation and Ogilvie Syndrome: A Case Report.
Topics: Analgesics, Opioid; Colonic Pseudo-Obstruction; Constipation; Decompression, Surgical; Humans; Hydromorphone; Intestinal Perforation; Low Back Pain; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Postoperative Complications; Quaternary Ammonium Compounds; Spinal Stenosis | 2019 |
Use of opioids for pain relief while driving: when the patient meets the police.
Topics: Aged; Analgesics, Opioid; Automobile Driving; Humans; Low Back Pain; Male; Naloxone; Oxycodone; Tramadol | 2013 |
A 37-year-old man with chronic low back pain and substance abuse.
Topics: Adult; Alcohol-Related Disorders; Chronic Pain; Humans; Low Back Pain; Male; Opioid-Related Disorders; Oxycodone; Risk Factors | 2015 |
ACP Journal Club. In acute low back pain, adding oxycodone/acetaminophen or cyclobenzaprine to naproxen did not improve pain or function.
Topics: Acetaminophen; Amitriptyline; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Low Back Pain; Male; Muscle Relaxants, Central; Naproxen; Oxycodone | 2016 |
PURLs: More isn't better with acute low back pain treatment.
Topics: Acetaminophen; Amitriptyline; Drug Combinations; Female; Humans; Low Back Pain; Male; Muscle Relaxants, Central; Naproxen; Oxycodone; Pain Measurement; Randomized Controlled Trials as Topic; Treatment Outcome | 2016 |
Second-Order Peer Reviews of Clinically Relevant Articles for the Physiatrist: Naproxen with Cyclobenzaprine, Oxycodone/Acetaminophen, or Placebo to Treating Acute Low Back Pain: A Randomized Clinical Trial.
Topics: Acetaminophen; Amitriptyline; Humans; Low Back Pain; Naproxen; Oxycodone; Peer Review; Physiatrists | 2017 |
Factors affecting acceptability of titrated oxymorphone extended release in chronic low back pain - an individual patient analysis.
Topics: Aged; Analgesics, Opioid; Chronic Disease; Clinical Trials, Phase III as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Low Back Pain; Male; Middle Aged; Oxycodone; Oxymorphone; Pain Measurement; Patient Acceptance of Health Care; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Treatment Outcome | 2010 |
False-positive buprenorphine EIA urine toxicology results due to high dose morphine: a case report.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Disease; Enzyme Assays; False Positive Reactions; Gas Chromatography-Mass Spectrometry; Humans; Low Back Pain; Male; Middle Aged; Morphine; Oxycodone; Reagent Kits, Diagnostic | 2012 |
Prescription for addiction?
Topics: Adult; Analgesics, Opioid; Female; Humans; Low Back Pain; Opioid-Related Disorders; Oxycodone | 2001 |
Clinical considerations in the treatment of chronic pain with opiates.
Topics: Accidents, Traffic; Alcoholism; Analgesics, Opioid; Chronic Disease; Depression; Humans; Low Back Pain; Male; Middle Aged; Morphine; Opioid-Related Disorders; Oxycodone; Pain | 2006 |
Opioid therapy for chronic painful conditions.
Topics: Analgesics, Opioid; Chronic Disease; Clinical Trials as Topic; Fentanyl; Humans; Karnofsky Performance Status; Low Back Pain; Methadone; Morphine; Opioid-Related Disorders; Oxycodone; Pain; Patient Selection; Practice Guidelines as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Time Factors | 2001 |